In other prescription drug news, the head of Turing Pharmaceuticals says the company's decision to raise the parasitic infection treatment Daraprim to $750 a pill from $13.50 a pill "doesn't affect the system at all." In other pharma news, The New York Times reports on the Coalition for Affordable Drugs, a company set up to challenge weak or abusive patents.
No comments:
Post a Comment